Life Sciences
Omega Diagnostics Group plc
Year
2019
Transaction type Equity Capital Markets & Corporate Broking
Sector Life Sciences
finnCap have advised Omega (AIM: ODX), the medical diagnostics company focused on allergy, food intolerance and infectious disease on their £1.7m fundraising.
The net proceeds of the Fundraising will be used for working capital purposes and to continue the commercialisation of both versions of the VISITECT® CD4 test.
Follow us
Related News
Impact of June Spending Review on UK equities
June 12, 2025
HealthTech Insights
February 19, 2025
Leveraging the UK’s Healthcare & Life Science Sector
August 19, 2024
AI Strategy and Guidance
July 24, 2024
Update to the QCA Code
July 2, 2024